Most patients with diffuse large B‐cell lymphoma (DLBCL) are diagnosed at age 60 years or
older. Challenges to effective therapy among older individuals include unfavorable biologic …

Opinion statement Patients with hematologic malignancies and their families are among the
most distressed of all those with cancer. Despite high palliative care-related needs, the …

PURPOSE Evidence suggests that adolescents and young adults (AYAs) with cancer
(defined as age 15-39 years) receive high-intensity (HI) medical care at the end-of-life …

Simple Summary Goals-of-care discussions can help patients to understand their illness and
to share their values and treatment preferences with their clinicians. Here, we compared the …

Context Many adolescents and young adults (AYAs; 15–39 years) with cancer receive high
intensity (HI) care at the end of life (EOL). Palliative care (PC) involvement in this population …

Objectives To compare end‐of‐life (EOL) care for solid tumor and hematologic malignancy
(HM) patients. Methods We collected data on the last 100 consecutive deceased HM and …

Purpose Anticancer drug use at the end of life places potential extra burdens on patients
and the healthcare system. Previous articles show variability in methods and outcomes; …

Background Adolescents and young adults (AYAs) with cancer may experience elevated
rates of high‐intensity end‐of‐life (HI‐EOL) care. Locus‐of‐care (LOC) disparities (pediatric …

Abstract Purpose of Review The medical field has a critical role not only in prolonging life
but also in helping patients achieve a good death. Early studies assessing end-of-life quality …

PURPOSE Hospice is underutilized by patients with hematologic malignancies (HM), and
when patients are referred, they are typically more ill, hospitalized, and with shorter length of …